If you are demanding any product or service please register as Farmavita.Net network member and publish your offer or demad. In-Licensing and oursoucing of products is usual a way for development of winning portfolio of products. License-in is also very cost effective way of product/technology development. Opportunities are listed according chronological order, the most recent first.

East Europe

rss
 
noimage.gif
Profitable and Modern Russian CMO with long term contracts for sale Founded in 2011, State of the art, audited by TOP MNC pharma companies, CMO located in Moscow area with comfortable transport junction, Long-term contract manufacturing agreements (packaging) with 5+ TOP MNC pharmaceutical companies. Total area - 1.600 m2, including equipment stock, analytical laboratory and microbiological laboratory. CMO contracts includes primary and...
noimage.gif

Tacrolimus

New Buy
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
1 330px-Alimemazine.svg_list.png
OUT-LICENSING HYBRID DOSSIER OF ALIMEMAZINE TABLETS OF 20 MG (GENERIC OF THERALAN / SANOFI), WITH B.E. STUDIES finalized in December 2016. THE DOSSIER IS AVAILABLE FOR OUT-LLICENISNG AND SUPPLY FOR ALL COUNTRIES EXCEPT FOR THE NORDICS (SE, NO, FI, DK). THE STRENGHT OF 20 MG IS UNIQUE AND EVEN THE INNOVATOR DOES NOT HAVE IT. PLEASE KINDLY CONTACT ME FOR MORE DETAILS. THANK YOU IN ADVANCE! BEST REGARDS.
noimage.gif
OUT-LICENSING DOSSIER OF ALIMEMAZINE TABLETS OF 5 MG, 10 MG AND 20 MG (GENERIC OF THERALAN / SANOFI), WITH B.E. STUDIES. THE DOSSIER IS AVAILABLE FOR OUT-LLICENISNG AND SUPPLY FOR ALL COUNTRIES EXCEPT FOR THE NORDICS (SE, NO, FI, DK). THE STRENGHT OF 20 MG IS UNIQUE AND EVEN THE INNOVATOR DOES NOT HAVE IT. PLEASE KINDLY CONTACT ME FOR MORE DETAILS. THANK YOU IN ADVANCE! BEST REGARDS.

Advert search

Recent adverts

I’m a representative of Parafarm (Penza,...
31 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
36 Views
Profitable and Modern Russian CMO with long...
29 Views
Adalimumab API available: - from EU cGMP...
9719 Views
Infliximab API available: - from EU cGMP...
35 Views
Normal 0 false false false EN-US X-NONE HE /*...
32 Views
Start-up pharmaceutical company from South...
1331 Views